TERF2
Basic information
Region (hg38): 16:69355566-69408571
Previous symbols: [ "TRBF2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (16 variants)
- Inborn genetic diseases (12 variants)
- TERF2-related condition (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TERF2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 13 | 15 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 1 | 1 | ||||
non coding ? | 11 | 11 | ||||
Total | 0 | 0 | 13 | 1 | 14 |
Variants in TERF2
This is a list of pathogenic ClinVar variants found in the TERF2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-69356678-T-C | Benign (Jun 15, 2019) | |||
16-69356739-G-A | Benign (Jun 14, 2019) | |||
16-69356756-C-T | Benign (Jun 27, 2019) | |||
16-69356799-C-CA | Benign (Aug 15, 2019) | |||
16-69357014-G-C | not specified | Uncertain significance (Oct 06, 2021) | ||
16-69357756-C-A | Benign (Jun 27, 2019) | |||
16-69357811-C-G | Benign (Jun 14, 2019) | |||
16-69361309-G-A | Benign (Jun 15, 2019) | |||
16-69361455-C-T | not specified | Uncertain significance (Dec 08, 2021) | ||
16-69361489-T-C | not specified | Likely benign (Jan 03, 2024) | ||
16-69361531-A-G | Benign (Jun 14, 2019) | |||
16-69366825-G-C | not specified | Uncertain significance (Sep 06, 2022) | ||
16-69366844-C-T | not specified | Uncertain significance (Sep 20, 2023) | ||
16-69366877-C-T | not specified | Uncertain significance (Oct 17, 2023) | ||
16-69366888-T-C | not specified | Uncertain significance (Jan 18, 2023) | ||
16-69366892-G-C | Benign (Apr 04, 2018) | |||
16-69366895-C-G | not specified | Uncertain significance (Oct 27, 2022) | ||
16-69366978-G-A | not specified | Uncertain significance (Dec 08, 2023) | ||
16-69366998-C-T | TERF2-related disorder | Likely benign (May 28, 2019) | ||
16-69367020-T-C | not specified | Uncertain significance (Jul 06, 2021) | ||
16-69367048-C-T | not specified | Uncertain significance (Nov 21, 2022) | ||
16-69367065-G-A | not specified | Likely benign (Feb 12, 2024) | ||
16-69367152-G-A | not specified | Uncertain significance (Mar 02, 2023) | ||
16-69367182-G-T | Benign (Feb 25, 2018) | |||
16-69368349-C-T | Benign (Jun 14, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TERF2 | protein_coding | protein_coding | ENST00000603068 | 10 | 53011 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.992 | 0.00763 | 125743 | 0 | 5 | 125748 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.07 | 170 | 265 | 0.642 | 0.0000136 | 3244 |
Missense in Polyphen | 52 | 105.17 | 0.49444 | 1327 | ||
Synonymous | 1.57 | 84 | 104 | 0.805 | 0.00000585 | 992 |
Loss of Function | 4.10 | 2 | 23.4 | 0.0855 | 0.00000115 | 282 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000446 | 0.0000439 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Binds the telomeric double-stranded 5'-TTAGGG-3' repeat and plays a central role in telomere maintenance and protection against end-to-end fusion of chromosomes. In addition to its telomeric DNA-binding role, required to recruit a number of factors and enzymes required for telomere protection, including the shelterin complex, TERF2IP/RAP1 and DCLRE1B/Apollo. Component of the shelterin complex (telosome) that is involved in the regulation of telomere length and protection. Shelterin associates with arrays of double-stranded 5'-TTAGGG-3' repeats added by telomerase and protects chromosome ends; without its protective activity, telomeres are no longer hidden from the DNA damage surveillance and chromosome ends are inappropriately processed by DNA repair pathways. Together with DCLRE1B/Apollo, plays a key role in telomeric loop (T loop) formation by generating 3' single- stranded overhang at the leading end telomeres: T loops have been proposed to protect chromosome ends from degradation and repair. Required both to recruit DCLRE1B/Apollo to telomeres and activate the exonuclease activity of DCLRE1B/Apollo. Preferentially binds to positive supercoiled DNA. Together with DCLRE1B/Apollo, required to control the amount of DNA topoisomerase (TOP1, TOP2A and TOP2B) needed for telomere replication during fork passage and prevent aberrant telomere topology. Recruits TERF2IP/RAP1 to telomeres, thereby participating in to repressing homology- directed repair (HDR), which can affect telomere length. {ECO:0000269|PubMed:16166375, ECO:0000269|PubMed:20655466, ECO:0000269|PubMed:9476899}.;
- Pathway
- Hematopoietic Stem Cell Gene Regulation by GABP alpha-beta Complex;Packaging Of Telomere Ends;Telomere Maintenance;Chromosome Maintenance;Cell Cycle;Regulation of Telomerase;ATM pathway
(Consensus)
Recessive Scores
- pRec
- 0.190
Intolerance Scores
- loftool
- 0.346
- rvis_EVS
- 0.22
- rvis_percentile_EVS
- 68.13
Haploinsufficiency Scores
- pHI
- 0.546
- hipred
- Y
- hipred_score
- 0.771
- ghis
- 0.478
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.907
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Terf2
- Phenotype
- liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cellular phenotype;
Gene ontology
- Biological process
- telomere maintenance;RNA-dependent DNA biosynthetic process;regulation of transcription by RNA polymerase II;cell cycle;positive regulation of gene expression;negative regulation of gene expression;telomere capping;telomeric loop formation;protection from non-homologous end joining at telomere;regulation of telomere maintenance;negative regulation of telomere maintenance;negative regulation of telomere maintenance via recombination;regulation of telomere maintenance via telomerase;negative regulation of telomere maintenance via telomerase;negative regulation of telomere maintenance via semi-conservative replication;positive regulation of nitric-oxide synthase activity;telomeric D-loop disassembly;protein localization to chromosome, telomeric region;cellular senescence;anterograde axonal transport of messenger ribonucleoprotein complex;negative regulation of beta-galactosidase activity;negative regulation of telomere single strand break repair;negative regulation of telomere capping;negative regulation of telomere maintenance via telomere lengthening;negative regulation of t-circle formation;negative regulation of exonuclease activity;negative regulation of telomeric D-loop disassembly;negative regulation of cellular senescence
- Cellular component
- chromosome, telomeric region;nuclear telomere cap complex;nuclear chromosome, telomeric region;nucleus;nucleoplasm;nuclear body;Mre11 complex;shelterin complex;axon cytoplasm
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;double-stranded telomeric DNA binding;telomerase activity;protein binding;protein C-terminus binding;enzyme binding;telomeric DNA binding;protein homodimerization activity;protein-containing complex binding;G-rich strand telomeric DNA binding